Repertoire Partners LP Takes Position in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Repertoire Partners LP bought a new stake in Integral Ad Science Holding Corp. (NASDAQ:IAS) in the third quarter, Holdings Channel.com reports. The firm bought 155,000 shares of the company’s stock, valued at approximately $1,676,000. Integral Ad Science makes up about 1.9% of Repertoire Partners LP’s holdings, making the stock its 9th biggest position.

A number of other hedge funds have also modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Integral Ad Science during the second quarter worth about $4,724,000. Nisa Investment Advisors LLC increased its position in Integral Ad Science by 449,805.3% during the second quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock worth $4,154,000 after purchasing an additional 427,315 shares during the last quarter. abrdn plc increased its position in Integral Ad Science by 12.5% during the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock worth $23,216,000 after purchasing an additional 237,930 shares during the last quarter. Invenomic Capital Management LP increased its position in Integral Ad Science by 57.4% during the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after purchasing an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC acquired a new stake in Integral Ad Science during the third quarter worth about $1,795,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Trading Down 1.9 %

NASDAQ IAS opened at $11.11 on Thursday. The firm has a 50 day simple moving average of $11.11 and a 200-day simple moving average of $10.61. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. Integral Ad Science Holding Corp. has a one year low of $7.98 and a one year high of $17.53. The firm has a market cap of $1.81 billion, a price-to-earnings ratio of 55.55, a PEG ratio of 1.59 and a beta of 1.45.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million during the quarter, compared to analyst estimates of $138.06 million. During the same quarter last year, the firm posted ($0.09) earnings per share. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Equities research analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Lisa Utzschneider sold 10,481 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares in the company, valued at $2,423,457.99. The trade was a 4.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Tania Secor sold 6,643 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $11.24, for a total transaction of $74,667.32. Following the sale, the chief financial officer now directly owns 251,366 shares in the company, valued at approximately $2,825,353.84. The trade was a 2.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock worth $240,296 over the last 90 days. 2.00% of the stock is owned by insiders.

Analysts Set New Price Targets

IAS has been the subject of several recent analyst reports. Piper Sandler cut their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a research report on Wednesday, November 13th. Craig Hallum cut their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Truist Financial dropped their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Oppenheimer dropped their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Finally, Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $15.70.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.